Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Nonoxynol-9 Spermicide Formulation and Supply

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract outlines the supply of pharmacologically compliant Nonoxynol-9 spermicide specifically formulated for use in lubricated condoms, ensuring it meets all required safety, stability, and human use standards. The product must be manufactured and delivered in full compliance with regulatory specifications to guarantee effectiveness and compatibility with condom materials under varying environmental conditions. The subcontract is issued under the NAICS code 325412, indicating it pertains to pharmaceutical and medicinal product manufacturing, and is managed by the Department of Defense through its Medical Supply Chain division. The solicitation was posted on August 5, 2026, with a strict response deadline of August 11, 2026, leaving a limited window for interested parties to submit proposals. The place of performance is designated as FPO with ZIP code 09588-2304, indicating delivery to a military postal location, likely supporting global defense medical logistics. Although no point of contact or set-aside details are provided, the contract is explicitly classified as a subcontract, meaning it is part of a broader procurement chain managed by a prime contractor under the Department of Defense. All submissions must adhere to the technical and administrative requirements specified in the DIBBS platform listing for SPE2DS26T314B.

General Info

Supply of Nonoxynol-9 spermicide for military condoms, compliant with pharmaceutical standards, delivered to FPO 09588-2304.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSFView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FPO, AE, 09588-2304, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of pharmacologically compliant Nonoxynol-9 spermicide for use in lubricated condoms, meeting safety and stability standards for human use.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9402
The Department of War, through the Defense Health Agency, is soliciting quotes under RFQ HT9402-26-Q-9402 to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by 10 U.S.C. § 1074g and 32 CFR § 199.21. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine placement on the Uniform Formulary as generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary, with the goal of optimizing pharmaceutical procurement through Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements. Four newly approved drugs—Awiqli Flextouch (basal insulin), Cavhanza (BCR-ABL tyrosine kinase inhibitor for leukemia and lymphoma), Lipfendra (PCSK9 antilipidemic), and Trutakna (nephrology agent)—are scheduled for review at the November 2026 Pharmacy and Therapeutics Committee meeting, and industry responses will inform their inclusion or exclusion. Responses to the RFQ are due by August 27, 2026, with a pre-quotation teleconference scheduled for August 12, 2026, to clarify requirements. Clinical data submissions for evaluation must be sent via email to the designated point of contact by the deadline specified in Part 2.3.2. The solicitation, issued by the Defense Health Agency under NAICS code 325412, is managed from Aurora, Colorado, with performance centered in San Antonio, Texas. Primary contact is Julia Trang, with Stephanie Erpelding as secondary contact, and all submissions and inquiries must adhere to the instructions outlined in RFQ HT9402-26-Q-9402 to be considered valid.
Defense Health Agency

POSTED

about 18 hours ago

DEADLINE

in 20 days
View Details
NAICS: 325412
New
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9401
The Department of War, through the Defense Health Agency, is soliciting quotations to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by federal law and regulation. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine their placement on the formulary tiers—generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary—with the goal of optimizing patient access and managing expenditures. The solicitation includes the potential award of Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements contingent upon the Pharmacy and Therapeutics Committee’s recommendations. Two drug classes are under review for the November 2026 meeting: Atopy—Topical Agents including Anzupgo, Eucrisa, Opzelura, Vtama, and Zoryve; and Lung Cancer—METEX14, including Tabrecta and Tepmetko. The request for quotation, identified as HT9402-26-Q-9401, outlines detailed procedures, appendices for BPA and ADP, and key submission deadlines. Responses are required by October 1, 2026, with a mandatory pre-quotation teleconference scheduled for August 12, 2026. The solicitation is issued by the Defense Health Agency under the Department of Defense, with the primary point of contact located in Aurora, Colorado, and performance expected in Texas. Vendors must adhere strictly to the instructions provided in the RFQ to ensure eligibility for consideration under the uniform formulary program, which directly impacts pharmacy benefits for military personnel and their dependents.
Defense Health Agency

POSTED

about 18 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 325412
New
DIBBS
Veterinary Pharmaceutical Tablet SupplierThe contract requires the manufacture and supply of Maropitant Citrate 160mg veterinary tablets packaged in blister packs containing four tablets per sheet, fully compliant with FDA and Defense Logistics Agency specifications. The product must meet all regulatory and quality standards for veterinary use, with strict adherence to packaging, labeling, and stability requirements to ensure efficacy and safety during storage and transport. The supplier is expected to deliver consistent, high-quality output in accordance with pharmaceutical manufacturing best practices, and all materials must be traceable and documented to support federal procurement compliance. This subcontract is issued under the Medical Supply Chain Pharm FSA, a division of the Department of Defense, with performance required at the APO ZIP code 09227-0000. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026, indicating a tight turnaround for proposals. The NAICS code 325412 identifies this as a pharmaceutical and biological product manufacturing contract, emphasizing the technical and regulatory expertise necessary for participation. While no set-aside details are provided, the contract is open to qualified subcontractors capable of meeting DoD’s stringent pharmaceutical supply chain requirements, with all deliverables aligned to ensure uninterrupted availability of critical veterinary medications for military and associated personnel.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Same awarding agency

NAICS: 326299
New
DIBBS
Manufacturing of Sterile Abdominal PadsThe contract requires full-scale manufacturing of sterile abdominal pads compliant with military and federal specifications, encompassing every stage of production from sourcing raw materials through fabrication, rigorous quality control, proper packaging, and terminal sterilization to ensure sterility and readiness for medical use. The work must adhere strictly to standardized protocols for performance, safety, and durability, aligning with the demands of defense medical supply chains. Production is expected to meet exacting standards for consistency and reliability, as these pads are intended for field and clinical applications within federal healthcare systems. The solicitation is classified as a subcontract under NAICS code 326299, with a response deadline of August 11, 2026, and a posted date of August 5, 2026. The place of performance is designated as Fort Stewart, Georgia, with a zip code of 31314-5674, indicating that operational logistics, delivery, or final assembly must occur at or near this military installation. The contract is managed by the Department of Defense through its MEDICAL SUPPLY CHAIN MD SURG FSF office, signaling a direct alignment with military medical readiness priorities. All submitted proposals must demonstrate proven capability in sterile medical product manufacturing and compliance with federal regulatory and defense procurement requirements.
All Other Rubber Product Manufacturing

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 339112
New
DIBBS
Disposable Tracheal Tube Stylets SupplyThe contract is for the supply of sterile, disposable tracheal tube stylets constructed with aluminum and PVC coating, specifically designed to fit endotracheal tubes with an inner diameter ranging from 7.5 mm to 10 mm for use in airway management procedures. These stylets are intended for single-use in clinical settings and must meet strict sterility and performance standards to ensure safe and reliable intubation. The procurement is issued as a subcontract under the NAICS code 339112, which classifies it within the medical equipment and supplies manufacturing sector. The offering is part of the Department of Defense’s Medical Supply Chain initiative, managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, with performance required at Fort Stewart, Georgia, under the zip code 31314-5185. Responses to this solicitation must be submitted by August 11, 2026, with the request published on August 5, 2026, through the DIBBS platform. There is no set-aside classification specified, meaning the opportunity is open to all qualifying contractors without restrictions based on business size or ownership type. While no specific point of contact is listed, interested parties are directed to the public DIBBS link for full documentation and submission instructions. The stylets must conform to all applicable regulatory and technical specifications for medical devices, including sterility, biocompatibility, and mechanical integrity, to ensure compatibility with standard endotracheal tubes used in military and civilian healthcare environments.
Surgical and Medical Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 4 days
View Details